AdminSep 21, 2021< 1 min read

Johnson & Johnson announces real-world evidence and Phase 3 data confirming strong and long-lasting protection of single-shot COVID-19 vaccine in the U.S.

Johnson & Johnson announced new data confirming the durability and efficacy of its COVID-19 vaccine, with real-world evidence indicating strong protection against hospitalizations and deaths, and a booster shot increasing protection against COVID-19, while maintaining a consistent safety profile.

Read More

Johnson & Johnson announces real-world evidence and Phase 3 data confirming strong and long-lasting protection of single-shot COVID-19 vaccine in the U.S.

Admin

RELATED ARTICLES